Palliative percutaneous drainage in malignant biliary obstruction. Part 1: Indications and preprocedure evaluation

Journal of Supportive Oncology

Volumn 4, Issue 6, 2006, Pages 269-273

  Covey, Anne M ^a   Brown, Karen T ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; PIPERACILLIN PLUS TAZOBACTAM;

ANATOMICAL VARIATION; ANTIBIOTIC PROPHYLAXIS; BILE DUCT CANCER; BILE DUCT OBSTRUCTION; CANCER PALLIATIVE THERAPY; CHOLANGITIS; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG EXCRETION; ENDOSCOPIC SURGERY; FATTY LIVER; HUMAN; IMAGE QUALITY; IMAGE RECONSTRUCTION; INFECTION PREVENTION; JAUNDICE; LIVER FUNCTION; LIVER PARENCHYMA; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; PERCUTANEOUS DRAINAGE; POSTOPERATIVE INFECTION; PREOPERATIVE EVALUATION; PROGNOSIS; PRURITUS; REVIEW; SEPSIS; STENT; SURGICAL TECHNIQUE; SYMPTOM; THREE DIMENSIONAL IMAGING; TREATMENT INDICATION; TREATMENT PLANNING;

CHOLANGITIS; CHOLESTASIS; DRAINAGE; HUMANS; HYPERBILIRUBINEMIA; JAUNDICE, OBSTRUCTIVE; MAGNETIC RESONANCE IMAGING; PALLIATIVE CARE; PRURITUS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33746973896     PISSN: 15446794     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Huard Do-Xuan Hop. La ponction transhepatique des canaux biliares [in French]. Bull Soc Med-Chir de l'Indochine 1937;15:785-803.
2. Jarnagin WR, Burke E, Powers C, Fong Y, Blumgart LH. Intrahepatic biliary enteric bypass provides effective palliation in selected patients with malignant obstruction at the hepatic duct confluence. Am J Surg 1998;175:453-460.
3. House MG, Choti MA. Palliative therapy for pancreatic/biliary cancer. Surg Oncol Clin N Am 2004;13:491-503.
4. Shankar A, Taylor I. Clinical examination and investigation. In: Blumgart LH, Fong Y, ed. Surgery of the Liver and Biliary Tract. 3rd ed. London: Saunders; 2000.
5. Van Laethem JL, De Broux S, Eisendrath P, et al. Clinical impact of biliary drainage and jaundice resolution in patients with obstructive metastases at the hilum. Am J Gastroenterol 2003;98:1271-1277.
6. Padillo FJ, Andicoberry B, Naranjo A, et al. Anorexia and the effect of internal biliary drainage on food intake in patients with obstructive jaundice. J Am Coll Surg 2001;192:584-590.
7. Bartholomew TC, Summerfield JA, Billing BH, Lawson AM, Setchell KD. Bile acid profiles of human serum and skin interstitial fluid and their relationship to pruritus studied by gas chromatography-mass spectrometry. Clin Sci (Lond) 1982;63:65-73.
8. Abraham NS, Barkun JS, Barkun AN. Palliation of malignant biliary obstruction: a prospective trial examining impact on quality of life. Gastrointest Endosc 2002;56:835-841.
9. Ballinger AB, McHugh M, Catnach SM, Alstead EM, Clark ML. Symptom relief and quality of life after stenting for malignant bile duct obstruction. Gut 1994;35:467-470.
10. Ozden I, Tekant Y, Bilge O, et al. Endoscopic and radiologic interventions as the leading causes of severe cholangitis in a tertiary referral center. Am J Surg 2005;189:702-706.
11. Tomioka M, Iinuma H, Okinaga K. Impaired Kupffer cell function and effect of immunotherapy in obstructive jaundice. J Surg Res 2000;92:276-282.
12. Clements WD, McCaigue M, Erwin P, Halliday I, Rowlands BJ. Biliary decompression promotes Kupffer cell recovery in obstructive jaundice. Gut 1996;38:925-931.
13. Katz S, Yang R, Rodefeld MJ, Folkening WJ, Grosfeld JL. Impaired hepatic bacterial clearance is reversed by surgical relief of obstructive jaundice. J Pediatr Surg 1991;26:401-405.
14. Vane DW, Redlich P, Weber T, et al. Impaired immune function in obstructive jaundice. J Surg Res 1988;45:287-293.
15. Singhal D, van Gulik TM, Gouma DJ. Palliative management of hilar cholangiocarcinoma. Surg Oncol 2005;14:59-74.
16. Rerknimitr R, Kladcharoen N, Mahachai V, Kullavanijava P. Result of endoscopic biliary drainage in hilar cholangiocarcinoma. J Clin Gastroenterol 2004;38:518-523.
17. Lee BH, Choe DH, Lee JH, Kim KH, Chin SY. Metallic stents in malignant biliary obstruction: prospective long-term clinical results. Am J Roentgenol 1997;168;741-745.
18. Mathieson JR, McLoughlin RF, Cooperberg PL, et al. Malignant obstruction of the common bile duct: long-term results of Gianturco-Rosch metal stents used as initial treatment. Radiology 1994;192:663-667.
19. Wagner HJ, Knyrim K, Vakil N, Klose KJ. Plastic endoprostheses versus metal stents in the palliative treatment of malignant hilar biliary obstruction: a prospective and randomized trial. Endoscopy 1993;25:213-218.
20. Bismuth H, Corlette MB. Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver. Surg Gynecol Obstet 1975;140:170-178.
21. Zhai R, Qian X, Dai D, Yu P. Malignant biliary obstruction:treatment with interventional radiology. Chin Med J (Engl) 2003;116:888-892.
22. Lee JW, Han JK, Kim TK, et al. Obstructive jaundice in hepatocellular carcinoma: response after percutaneous transhepatic biliary drainage and prognostic factors. Cardiovasc Intervent Radiol 2002;25:176-179.
23. Inal M, Akgül E, Aksungur A, Seydao lu G. Percutaneous placement of biliary metallic stents in patients with malignant hilar obstruction: unilobar versus bilobar drainage. J Vasc Interv Radiol 2003;14:1409-1416.
24. Hann LE, Getrajdman GI, Brown KT, et al. Hepatic lobar atrophy: association with ipsilateral portal vein obstruction. Am J Roentgenol 1996;167:1017-1021.
25. Xu AM, Cheng HY, Jiang WB, et al. Multi-slice three-dimensional spiral CT cholangiography: a new technique for diagnosis of biliary diseases. Hepatobiliary Pancreat Dis Int 2002;1:595-603.
26. Brody LA, Brown KT, Getrajdman GI, et al. Clinical factors associated with positive bile cultures during primary percutaneous biliary drainage. J Vasc Interv Radiol 1998;9:572-578.
27. Westphal JF, Brogard JM, Caro-Sampara F, et al. Assessment of biliary excretion of piperacillin-tazobactam in humans. Antimicrob Agents Chemother 1997;41:1636-1640.